Humanigen Inc (HGENQ)

[jimmy667]

Looks like it will be the three remaining mAbs for the win. All three as each will be useful and important. All the mAbs from BP have failed or not looking too good. So it is down to Leronlimab, Lenzilmab and Itolizimab from India. Others as well but looks like these three will reach the finish line. All three as all three will be needed. Even Gilead could not supply enough Remdisiver, Pfizer had to step up to help produce. So I see HGEN and CYDY both as big winners.